Lewis, Jo E.
Miedzybrodzka, Emily L.
Foreman, Rachel E.
Woodward, Orla R. M.
Kay, Richard G.
Goldspink, Deborah A.
Gribble, Fiona M.
Reimann, Frank
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council
Wellcome Trust (106263/Z/14/Z)
Medical Research Council (MRC_MC_UU_12012/3)
Article History
Received: 3 December 2019
Accepted: 3 March 2020
First Online: 27 April 2020
Authors’ relationships and activities
: The FR/FMG lab receives additional grant support from AstraZeneca, Eli Lilly and LGC for unrelated work. FMG is a consultant for Kallyope (New York, USA). DAG has started employment with GlaxoSmithKline since contributing to this work. All authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.